Ìåäèêî-áèîëîãè÷åñêèé
èíôîðìàöèîííûé ïîðòàë
äëÿ ñïåöèàëèñòîâ
 
Medline.ru

ÑÎÄÅÐÆÀÍÈÅ ÆÓÐÍÀËÀ:
Ôèçèêî-õèìè÷åñêàÿ áèîëîãèÿ

Êëèíè÷åñêàÿ ìåäèöèíà

Ïðîôèëàêòè÷åñêàÿ ìåäèöèíà

Ìåäèêî-áèîëîãè÷åñêèå íàóêè


ÀÐÕÈÂ:

Ôóíäàìåíòàëüíûå èññëåäîâàíèÿ

Îðãàíèçàöèÿ çäðàâîõðàíèåíèÿ

Èñòîðèÿ ìåäèöèíû è áèîëîãèè



Ïîñëåäíèå ïóáëèêàöèè

Ïîèñê ïóáëèêàöèé

Articles

Àðõèâ :  2000 ã.  2001 ã.  2002 ã. 
               2003 ã.  2004 ã.  2005 ã. 
               2006 ã.  2007 ã.  2008 ã. 
               2009 ã.  2010 ã.  2011 ã. 
               2012 ã.  2013 ã.  2014 ã. 
               2015 ã.  2016 ã.  2017 ã. 
               2018 ã.  2019 ã.  2020 ã.  2021 ã.  2022 ã.  2023 ã. 

Ðåäàêöèîííàÿ èíôîðìàöèÿ:
        Îïóáëèêîâàòü ñòàòüþ
        Íàøà ñòàòèñòèêà


 ÐÅÄÀÊÖÈß:
Ãëàâíûé ðåäàêòîð

Çàìåñòèòåëè ãëàâíîãî ðåäàêòîðà

×ëåíû ðåäêîëëåãèè
Ñïåöèàëèçèðîâàííûå ðåäêîëëåãèè


 Ó×ÐÅÄÈÒÅËÈ:
Èíñòèòóò òåîðåòè÷åñêîé è ýêñïåðèìåíòàëüíîé áèîôèçèêè Ðîññèéñêîé àêàäåìèè íàóê.

ÎÎÎ "ÈÖ ÊÎÌÊÎÍ".




Àäðåñ ðåäàêöèè è ðåêâèçèòû

199406, Ñàíêò-Ïåòåðáóðã, óë.Ãàâàíñêàÿ, ä. 49, êîðï.2

ISSN 1999-6314

Ðîññèéñêàÿ ïîèñêîâàÿ ñèñòåìà
Èñêàòü: 


«
Vol. 14, Art. 79 (pp. 993-1007)    |    2013       
»

The genetic factors, which define the different action’s effects of ethanol for an organism
Osechkina N.S., Nazarov G.V., Bonitenko E.J., Ivanov M.B., Kashuro V.A., Lapina N.V. Babkin A.V., Berdinskih I.S.

Federal State Scientific Institution «Institute of Toxicology Federal Medico-Biological Agency»



Brief summary

In the review are examined the genetic factors, which define the different action’s effects of ethanol for an organism. We’re talking about the meaning of genes which encode ethanol metabolism\'s ferments and receptors for neurotransmitters. Here were examined the polymorphisms genes, their level of expression as an association with risk of various pathological organism’s conditions. After analyzing the data this review we may make a conclusion more likely that reaction of the organism under the ethanol influence are determined genetically. Research for topical areas should include search connection the genetic characteristics with variability of the organism\'s response in acute ethanol intoxication.


Key words

ethanol, gene, polymorphism, expression, neurotransmitter, alcohol dependence, tolerance, intoxication.





(The article in PDF format. For preview need Adobe Acrobat Reader)



Open article in new window

Reference list

1. Bonitenko E.U., Nechiporenko S.P. Chrezvichainie sityacii himicheskoi prirodi // Rol toksikologicheskih centrov v obespechenii himicheskoi bezopasnosti na regionalnom yrovne. Naychno-prakticheskaya konferenciya. – Ekaterinbyrg: Izd. YGMA, 2011. – s. 14–16.


2. Semenova V.G., Antonova O.I., Evdokyshkina G.N., Gavrilova N.S. Poteri naseleniya Rossii v 2000-2008 gg., obyslovlennie alkogolem: masshtabi, stryktyra, tendencii // Socialnie aspekti zdorovya naseleniya: elektronnii naychnii jyrnal - 2010. – 01 iulya [Elektronnii resyrs]. URL: http://vestnik.mednet.ru/content/view/188/27/ (data obrasheniya: 10.12.2013).


3. Bonitenko E.U., Grebenuk A.N., Basharin V.A., Ivanov M.B., Makarova N.V. Ocenka nevrologicheskogo statysa pri ostroi alkogolnoi intoksikacii v eksperimente // Bulleten eksperimentalnoi biologii i medicini. – 2010. – T. 149., ¹ 3. – S. 300–303.


4. Bonitenko U.U. Ostrie otravleniya etanolom i ego syrrogatami. – SPb.: Izd-vo «ELBI-SPB», 2005. – 225 s.


5. Shangareeva Z.A., Viktorova T.V., Nasirov H.M., Sagidyllin A.F., Baikov I.R. Analiz polimorfizma genov ychastvyushih v metabolizme etanola y lic s alkogolnoi boleznu pecheni // Medicinskaya genetika. – 2003. – T. 2, ¹ 11. – S. 485-490.


6. Agarwal D.P. Genetic polymorphisms of alcohol metabolizing enzymes // Pathol. Biol. – 2001. – V. 49, ¹ 9. – P. 703-709.


7. Tabakoff B., Hoffman L. Neirobiologicheskie effekti alkogolya // Voprosi narkologii. – 2003. – ¹ 5. – S. 27–42.


8. Brennan P., Lewis S., Hashibe M. et al. Pooled analysis of alcohol dehydrogenase genotypes and head and neck Cancer: a HuGE Review // Am. J. Epidemiol. – 2004. – V. 159, ¹ 1. – P. 1-16.


9. Markizova N.F., Grebenuk A.N., Basharin V.A., Bonitenko E.U. Spirti: Seriya «Toksikologiya dlya vrachei». – SPb.: Foliant, 2004. – 112 s.


10. Zakhari S. Overview: how is alcohol metabolized by the body? // Alcohol Res Health. – 2006. – V.4., ¹ 29. – P. 245–254.


11. Garmash I.V., Arisheva O.S. Genetika i alkogolnii cirroz pecheni / Klinicheskaya gepatologiya. – 2013. - ¹ 9(1). - S.14-18.


12. Dolgo–Sabyrov V.B., Petrov A.N., Lisickii D.S., Belyaev V.A Centralnie neirohimicheskie effekti ostrogo i hronicheskogo vozdeistviya etanola. Mehanizmi tolerantnosti i zavisimosti (obzor literatyri) / Medline.ru.-2011.-T.12.- S. 1423-1436.


13. Hurley T.D., Edenberg H. J. Genes Encoding Enzymes Involved in Ethanol Metabolism // Alcohol Research: Current Reviews. – 2012. – V.34, ¹3. – R.339–344.


14. Severin, E.S. Biohimiya / E.S. Severin. – Moskva: Izd-vo GEOTAR-MED, 2003. – 779 s.


15. Quertemont, E. Genetic polymorphism in ethanol metabolism: acetaldehyde contribution to alcohol abuse and alcoholism / E. Quertemont // Molecular Psychiatry. – 2004. – V.9. – P. 570–581.


16. Gallelli, L. Pharmacology // L. Gallelli. – In Tech Europe. – 2012. – 720 r.


17. Marysin A.V., Stepanov V.A., Spiridonova M.G., Bohan N.A., Mandel A.I., Harkov V.N., Pels Ya.R., Pyzirev V.P. Polimorfizm genov etanol-metaboliziryushih fermentov ADH1B, ADH7 i CYP2E1, svyaz s riskom razvitiya alkogolizma, komorbidnogo s tyberkylezom, v rysskoi popylyacii Zapadno-Sibirskogo regiona // Medicinskaya genetika. – 2006. – ¹ 7. – S. 51–56.


18. Ashmarin I.P. Alkogoldegidrogenaza mlekopitaushih – obekt molekylyarnoi medicini // Ysp. biol. him. – 2003. – T. 43. – S. 3–18.


19. Macgregor S. et al. Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis // Hum. Mol. Genet. – 2009. – V. 18. – P. 580–593.


20. Nagata N., Hiyoshi M., Shiozawa H., Shiraishi K., Watanabe N., Tsuda M., Matsuzaki S. Assessment of a difference in ALDH2 heterozygotes and alcoholic liver injury // Alcohol Clin. Exp. Res. – 2002. – V. 26 (8 Suppl.): – R. 11S–14S.


21. Li D., Zhao H., Gelernter J. Strong protective effect of the aldehyde dehydrogenase gene (ALDH2) 504lys (*2) allele against alcoholism and alcohol-induced medical diseases in Asians // Hum. Genet. – 2012. – ¹ 131. – R. 725–737.


22. Vinogradova S.V. Rol geneticheskih faktorov v razvitii alkogolnoi bolezni pecheni // Sovremennie problemi toksikologii. – 2007. – ¹ 2. – S. 27–37.


23. Ingelman-Sundberg M. Human drug metabolizing cytochrome P450 enzymes: properties and polymorphisms // Naunyn-Schmiedeberg\'s Arch. Pharmacol. – 2004. – V. 369, ¹ 1. – P. 89–104.


24. Pirmohamed M. et al. Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians // Pharmacogenetics. – 1995. – V. 5. – P. 351–357.


25. Watanabe J., Hayashi S., Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to RsaI polymorphism in the 5’ flanking region // J. Biochem. – 1994. – V. 116, ¹ 2. – P. 321–326.


26. Danko I.M., Chaschin N.A. Association of CYP2E1 gene polymorphism with predisposition to cancer development // Exp. Oncol. – 2005. – P. 248–256.


27. Byshma M.I., Zimatkin S M . Ambryshkevich U.G., Legonkova L.F., Byshma T.V., Sheibak B.M. Eksperimentalnii analiz faktorov biologicheskoi predraspolojennosti k razvitiu alkogolnoi bolezni pecheni. / Narkologiya, – 2002. – ¹4. – S.12-15.


28. Ladero J.M. et al. RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma // Gut. – 1996. – V. 39. – P. 330–333.


29. Symin S.A. Neotlojnie sostoyaniya // S.A. Symin – Moskva: OOO «Medicinskoe informacionnoe agenstvo». – 2006. – 800 s.


30. Bonitenko E.U., Basharin V.A., Bonitenko U.U., Golovko A.I. , Ivanov M.B. Deprimiryushie agenti. Novie podhodi k klassifikacii Toksikologicheskii vestnik.-2012.-¹ 3.-S.43-46.


31. Blum K., Trachtenberg M.C. Neurogenic deficits caused by alcoholism // J. Psychoactive Drugs, 1988, Vol. 20, ¹3, p. 297-313.


32. Krystal J.H., Staley J., Mason G.F. et al. GABAA receptors and alcoholism: intoxication, dependence, vulnerability, and treatment // Arch. Gen. Psychiatry. – 2006. – Vol. 63. – P.957–968.


33. Golovko A.I., Barinov V.A., Basharin V.A., Bonitenko E.U., Ivanov M.B., Golovko S.I., Lapina N.V Mehanizmi farmakologicheskoi aktivnosti antideprimiryushih sredstv, deistvyushih na sistemi GAMK i glytaminovoi kisloti Medline.ru.-2012.-T.13 .-S. 157-184.


34. Shabanov P.D. Narkologiya: prakticheskoe rykovodstvo dlya vrachei. – Moskva: Izd-vo Geotar-Med, 2003. – 560 s.


35. Kylichkin S.S., Fashytdinova G.G., Kazanceva A.V. i dr. Molekylyarno-geneticheskoe izychenie nasledstvennoi predraspolojennosti k razvitiu hronicheskogo alkogolizma v popylyaciyah yakytov i evenkov respybliki Saha (Yakytiya) // Narkologiya –2012. – T. 11., ¹ 4 (124). – S. 48–55.


36. Kibitov A.O., Anohina I.P. Stryktyrnie osobennosti gena tirozingidroksilazi y bolnih s razlichnoi tyajestu techeniya alkogolizma // Voprosi narkologii – 2002. – ¹2. – S. 55–65.


37. Johnson B.A., Ait-Daoud, Seneviratne N. et al. Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking // Am. J. Psychiatry. – 2011. – V. 168, ¹ 3. – R. 265–275.


38. Vengeliene V., Bilbao A., Molander A., Spanagel R. Neuropharmacology of alcohol addiction // British Journal of Pharmacology. – 2008. – V. 154. – P. 299–315.


39. Faingold C., Li Y., Evans M. S. Decreased GABA and increased glutamate receptor–mediated activity on inferior colliculus neurons in vitro are associated with susceptibility to ethanol withdrawal seizures // Brain Res. – 2000. – Vol. 868, ¹ 2. – p. 287-295.


40. Devaud L.L. Ethanol dependence has limited effects on GABA or glutamate transporters in rat brain // Alcohol Clin. Exp. Res. – 2001. – Vol. 25, ¹ 4. – p. 606-611.


41. Graham A.R. GABAA Receptor channel pharmacology // Current Pharmaceutical Design. – 2005. – V. 11. – P. 1867–1885.


42. Breese G.R., Criswell H.E., Carta M., Dodson P.D. et al. Basis of the gaba mimetic profile of ethanol // Alcohol. Clin. Exp. Res. − 2006. − Vol. 30, ¹ 4. − P. 731−744.


43. Bonitenko E.U., Golovko A.I., Basharin V.A., Ivanov M.B., Petrov A.N., Makarova N.V. Algoritm eksperimentalnogo modelirovaniya toksicheskoi komi y kris // Medline.ru.-2010.-T.11 (st. 59).-S. 718-735.


44. Pierucci-Lagha A., Covault J., Feinn R. et al. GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride // Neuropsychopharmacology. –2005. – V.30, ¹6. – R.1193–1203.


45. Romanenko O.I., Golovko A.I., Shpilenya L.S. i dr. Fynkcionalnoe sostoyanie receptorov glytamata pri vozdeistviyah etanolom // Voprosi medicinskoi himii. – 1999. – ¹5. – S. 368–374.


46. Longo L.P., Campbell T., Hubatch S. Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention / L.P. Longo, T. Campbell, S. Hubatch, //J. Addict. Dis. – 2002. – V. 21, ¹. 2. – R. 55–64.


47. Sander T., Ostapowicz A. et al. Genetic variation of the glutamate transporter EAAT2 gene and vulnerability to alcohol dependence // Psychiatry Genet. – 2000. – V. 10, ¹ 3. – R. 103–107.


48. G. Schumann, M. Johann, J. Frank et al. Systematic analysis of glutaminergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior // Arch. Gen. Psychiatry. – 2008. – V. 65, ¹.7. – R. 826–838.



Ñâèäåòåëüñòâî î ðåãèñòðàöèè ñåòåâîãî ýëåêòðîííîãî íàó÷íîãî èçäàíèÿ N 077 îò 29.11.2006
Æóðíàë îñíîâàí 16 íîÿáðÿ 2000ã.
Âûäàíî Ìèíèñòåðñòâîì ÐÔ ïî äåëàì ïå÷àòè, òåëåðàäèîâåùàíèÿ è ñðåäñòâ ìàññîâûõ êîììóíèêàöèé
(c) Ïåðåïå÷àòêà ìàòåðèàëîâ ñàéòà Medline.Ru âîçìîæíà òîëüêî ñ ïèñüìåííîãî ðàçðåøåíèÿ ðåäàêöèè

Ðàçìåùåíèå ðåêëàìû

Rambler's Top100